Modeling Tau-Mediated Pathology in Monkey Brain Slices
Open Access
Abstract
Tau pathology is a hallmark feature of Alzheimer’s disease (AD) and is tightly associated with clinical manifestations. No disease-modifying therapy is currently available for AD, partly due to prominent interspecies differences in tau expression patterns between rodents and primates. To facilitate the investigation of primate-specific tau pathology, we developed an in vitro platform using monkey (Macaca fascicularis) brain slice cultures (BSC) that preserve native three-dimensional tissue architecture and maintain functional networks closely mirroring in vivo conditions. We systematically evaluated various adeno-associated virus (AAV) serotypes and promoter combinations to achieve efficient transgenic tau expression. Our data confirm that the monkey BSC system is highly amenable to AAV-mediated gene delivery, exhibiting robust transduction of glial cells with minimal cytotoxicity and allowing for the examination of glial pathology induced by disease-associated proteins. Notably, this platform is applicable to both juvenile and aged specimens, enabling comparative analyses of age-dependent susceptibility to pathological insults. Following overexpression of mutant human tau, we observed time-dependent tau pathology development within 2–4 weeks post-infection, including hyperphosphorylation and aggregation. This in vitro primate model offers a unique opportunity to dissect primate-specific pathological events. Furthermore, the scalability and reproducibility of this system render it ideally suited for drug screening, providing a more translationally relevant preclinical bridge between rodent models and human clinical trials.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFF0702201)
- Guangzhou Key Research Program on Brain Science (202007030008)
- Guangdong Provincial Department of Science and Technology (2021A1515012526)
- National Natural Science Foundation of China (82394422)
- National Natural Science Foundation of China (81830032)
- National Natural Science Foundation of China (81873736)
This publication has 79 references indexed in Scilit:
- Alzheimer's disease polygenic risk in early‐ and late‐onset Alzheimer's diseaseAlzheimer's & Dementia, 2026
- Blood‐based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings: A systematic review and meta‐analysisAlzheimer's & Dementia, 2025
- Recent advances in neuroimaging of Alzheimer's disease and related dementiasAlzheimer's & Dementia, 2025
- Early blood immune molecular alterations in cynomolgus monkeys with a PSEN1 mutation causing familial Alzheimer's diseaseAlzheimer's & Dementia, 2024
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- Comparative neuropathology in aging primates: A perspectiveAmerican Journal of Primatology, 2021
- A novel tau‐based rhesus monkey model of Alzheimer's pathogenesisAlzheimer's & Dementia, 2021
- Organotypic Brain Slice CulturesCurrent Protocols in Immunology, 2018
- Rodent Models of Amyotrophic Lateral SclerosisCurrent Protocols in Pharmacology, 2015
- Why primate models matterAmerican Journal of Primatology, 2014